HCMT
Highland Capital Management (Texas)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $2.65M | Sell |
119,825
-59,300
| -33% | -$1.31M | 0.15% | 93 |
|
|
2019
Q1 | $2.44M | Sell |
179,125
-51,000
| -22% | -$696K | 0.15% | 116 |
|
|
2018
Q4 | $2.08M | Buy |
230,125
+37,900
| +20% | +$343K | 0.16% | 111 |
|
|
2018
Q3 | $3.17M | Sell |
192,225
-70,555
| -27% | -$1.16M | 0.18% | 101 |
|
|
2018
Q2 | $3.68M | Sell |
262,780
-82,973
| -24% | -$1.16M | 0.21% | 95 |
|
|
2018
Q1 | $3.82M | Sell |
345,753
-146,577
| -30% | -$1.62M | 0.2% | 95 |
|
|
2017
Q4 | $4.33M | Buy |
492,330
+58,400
| +13% | +$514K | 0.2% | 96 |
|
|
2017
Q3 | $5.79M | Buy |
433,930
+55,700
| +15% | +$744K | 0.26% | 72 |
|
|
2017
Q2 | $5.43M | Hold |
378,230
| – | – | 0.23% | 91 |
|
|
2017
Q1 | $8M | Buy |
378,230
+20,975
| +6% | +$444K | 0.41% | 56 |
|
|
2016
Q4 | $10.1M | Sell |
357,255
-15,250
| -4% | -$429K | 0.47% | 55 |
|
|
2016
Q3 | $9.98M | Buy |
372,505
+45,461
| +14% | +$1.22M | 0.3% | 54 |
|
|
2016
Q2 | $5.52M | Buy |
+327,044
| New | +$5.52M | 0.23% | 92 |
|
|
2016
Q1 | – | Sell |
-223,662
| Closed | -$5.14M | – | 206 |
|
|
2015
Q4 | $5.14M | Buy |
223,662
+61,262
| +38% | +$1.41M | 0.16% | 121 |
|
|
2015
Q3 | $3.25M | Sell |
162,400
-40,400
| -20% | -$809K | 0.09% | 153 |
|
|
2015
Q2 | $5.86M | Buy |
202,800
+39,756
| +24% | +$1.15M | 0.12% | 137 |
|
|
2015
Q1 | $4.99M | Buy |
+163,044
| New | +$4.99M | 0.1% | 133 |
|